- Year selection
- 2022
- 2033
-
2026-08-05
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2026
-
2026-07-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026
-
2026-06-29
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON MONDAY, JUNE 29, 2026
-
2026-06-08
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, JUNE 29, 2026
-
2026-06-08
NOTICE OF THE ANNUAL GENERAL MEETING
-
2026-06-08
(1) ANNUAL REPORT FOR 2025 (2) REPORT OF THE BOARD OF DIRECTORS FOR 2025 (3) REPORT OF THE SUPERVISORY COMMITTEE FOR 2025 (4) FINANCIAL REPORT FOR 2025 (5) PROFIT DISTRIBUTION PLAN FOR 2025 (6) PROPOSED REAPPOINTMENT OF THE AUDITOR FOR 2026 (7) PROPOSED GRANTING OF GENERAL MANDATE TO ISSUE SHARES AND (8) NOTICE OF THE ANNUAL GENERAL MEETING
-
2026-06-03
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
-
2026-05-22
VOLUNTARY ANNOUNCEMENT DATA FROM TWO CLINICAL STUDIES OF M701 "CD3/EpCAM BISPECIFIC ANTIBODY" TO BE PRESENTED AT 2026 ASCO ANNUAL MEETING
-
2026-05-15
CHANGE OF EMPLOYEE REPRESENTATIVE SUPERVISOR
-
2026-05-07
VOLUNTARY ANNOUNCEMENT NDA FOR TREATMENT OF MA OF M701 WAS ACCEPTED BY THE NMPA
E-Mail：info@yzybio.com
Address：Biolake, C2-1, No. 666 High-tech Avenue, Wuhan, Hubei, China
